Scientific Advisory Board
The Scientific Advisory Board (SAB) is comprised of many notable scientists including the researcher who isolated the first Alzheimer’s gene, a scientist who helped decipher the genetic code, and two Nobel laureates. The SAB provides guidance to the Institute’s research program and assistance in forging alliances with institutions and companies around the world.
Chairman: |
| Rudolph Tanzi, Ph.D. Director, Genetics and Aging Unit Harvard Medical School |
Members: |
|
| Floyd E. Bloom, M.D. Chairman and Chief Executive Officer Neurome Inc. |
Louis J. DeFelice, Ph.D. Professor of Pharmacology Distinguished Professor Emeritus Vanderbilt University Medical Ctr |
| Robert Furchgott, Ph.D. * Distinguished Professor Emeritus SUNY |
Sam Gandy, M.D., PhD. Director, Farber Institute for Neurosciences Thomas Jefferson University |
| Jerome Kagan, Ph.D. Professor, Department of Psychology Harvard University |
Marshall Nirenberg, Ph.D. * Chief Laboratory of Biochemical Genetics National Institutes of Health |
| Sangram S. Sisodia, Ph.D. Thomas Reynolds Sr. Family Professor of Neurosciences Director, Center for Molecular Neurobiology The University of Chicago |
Peter J.S. Smith, Ph.D. Director, Program in Molecular Physiology Marine Biological Laboratory |
| George Spirou, Ph.D. |
James M Stevenson, MD |
| Paul A. Wender, Ph.D. Bergstrom Professor of Chemistry Stanford University |
Daniel Alkon, M.D., ex officio Scientific Director Blanchette Rockefeller Neurosciences Institute |
*Nobel Laureate
**Institute staff and boards cannot give medical advice in any form. Only a doctor who has examined the patient and reviewed the medical records can comment on individual patient issues. However, we are committed to responding to your inquiries. Please contact us if you want additional information.